Breitenecker G, Seidl A, Smekal G, Philipp K
Gynecol Obstet Invest. 1986;22(1):34-41. doi: 10.1159/000298887.
Solcogyn is a new acid preparation for the treatment of benign changes in the portio uteri. Histological and histochemical investigations of the treated cervix in patients scheduled for hysterectomy revealed a differential effect of this acid mixture in that ectocervical squamous epithelium was scarcely affected, while ectopic and endocervical cylindrical epithelium and the subepithelial stroma were devitalized by in vivo fixation. The maximum depth of penetration of the fixative effect was 2.5 mm. The treated cervical ectopies and transformation zones re-epithelialized within 3-4 weeks. The comparatively slight but sufficiently deep devitalization of affected tissue explains the clinical advantages observed with this preparation as compared to thermocoagulation and cryotherapy.
索尔科金是一种用于治疗子宫颈良性病变的新型酸制剂。对计划进行子宫切除术的患者的治疗宫颈进行组织学和组织化学研究发现,这种酸混合物具有差异性作用,即宫颈外鳞状上皮几乎未受影响,而异位和宫颈管柱状上皮以及上皮下基质则因体内固定而失活。固定作用的最大穿透深度为2.5毫米。经治疗的宫颈异位和转化区在3至4周内重新上皮化。与热凝术和冷冻疗法相比,受影响组织相对轻微但足够深的失活解释了该制剂所观察到的临床优势。